JD Health, the health care subsidiary of Chinese e-commerce firm JD.com, has filed for an initial public offering (IPO) to the Hong Kong Stock Exchange.

The company plans to raise $1.8bn to $2.8bn within the year and plans to hold a majority interest in JD Health after the IPO.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

JD Health operates an e-commerce platform and sells pharmaceutical products such as vitamins, supplements, medical devices and contact lenses.

JD.com’s healthcare business launched in 2014 and the company started online diagnosis services in 2017.

JD Health reportedly generated $1.3bn in revenue during the first half of 2020, registering a year-on-year growth of 76%.

The company recently raised over $830m from private equity firm Hillhouse Capital via its series B preference share financing.

Chinese tech giants sought to harness health-related businesses to drive growth, rolling out a wide range of services like online consultations, hospital reservations and pharmaceutical sales.

To drive growth during the Covid-19 pandemic and beyond, Chinese tech giants are focusing on harnessing health-related businesses with various services such as online consultations and hospital reservations.

JD Health competes with Ali Health, the healthcare subsidiary of Alibaba, Tencent-linked online medical services provider Wedoctor, as well as Ping An Insurance Group’s unit Pingan Good Doctor.

In June, JD Health unveiled its traditional Chinese medicine consultation centre and intelligent otorhinolaryngology services centre.

The centres bring together the country’s top specialists and offer online consultations and disease management programmes for patients nationwide.